vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Hudbay Minerals Inc. (HBM). Click either name above to swap in a different company.
Hudbay Minerals Inc. is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× BioNTech SE). Hudbay Minerals Inc. runs the higher net margin — 3.4% vs -1.9%, a 5.2% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Hudbay Minerals Inc. is a Canadian mining company that produces copper, gold, silver, zinc, and molybdenum. In 2024, the company produced 137,943 tonnes of copper, 332,240 ounces of gold, 3,983,851 ounces of silver, 33,339 tonnes of zinc, and 1,323 tonnes of molybdenum. In 2024, copper sales represented 57% of revenue, gold sales represented 33% of revenue, and zinc sales represented 4% of revenue.
BNTX vs HBM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.5B | $2.0B |
| Net Profit | $-28.7M | $67.8M |
| Gross Margin | — | 27.4% |
| Operating Margin | -3.1% | — |
| Net Margin | -1.9% | 3.4% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.0B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $260.8M | — | ||
| Q1 25 | — | $525.0M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.2B | — | ||
| Q1 24 | — | $295.2M |
| Q1 26 | — | $67.8M | ||
| Q3 25 | $-28.7M | — | ||
| Q2 25 | $-386.6M | — | ||
| Q1 25 | — | $18.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $198.1M | — | ||
| Q1 24 | — | — |
| Q1 26 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 29.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | 22.5% |
| Q1 26 | — | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -192.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.8% | — | ||
| Q1 24 | — | — |
| Q1 26 | — | 3.4% | ||
| Q3 25 | -1.9% | — | ||
| Q2 25 | -148.2% | — | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.9% | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.